Navigation Links
Discovery of a novel mechanism for the development of colon cancer
Date:5/5/2008

Recent work from the Finnish Academy Center of Excellence on Cancer Biology at the University of Helsinki, Finland, has shed light on the mechanisms of colon tumor development and may help to design better treatment for this disease.

Colon cancer is one of the most common malignancies in Western countries: both men and women face a lifetime risk of nearly 6% for the development of invasive colorectal cancer. Epidemiologic studies have shown that several factors contribute to the development of this disease, such as high fat, red-meat diet, obesity and lack of vegetables and fibre in the diet.

In the great majority of cases, colorectal cancer arises from an initially benign overgrowth of colonic lining, a so-called adenomatous polyp (Fig. 1), which acquires with time harmful mutations and transforms into a dangerous colonic carcinoma. Observational studies suggest that the adenoma-to-carcinoma sequence takes up to 10 years. Although nearly half of Western population may harbor adenomatous polyps by the age of 50, it is estimated that only a few percent of adenomas will progress to cancer.

The study published as an advance online publication of Cancer Cell, describe a mechanism by which harmless colon polyps acquire the ability to form malignant tumors. Researchers from the University of Helsinki discovered that PROX1, a protein that in embryos controls formation of normal organs, such as liver or eye, becomes abnormally overproduced at early stages of carcinoma development. PROX1 allows tumor cells to grow even in the absence of stimulating signals from surrounding normal tissues, which leads to dangerous overgrowth and development of advanced tumors.

Removal of PROX1 from cancer cells reverses their malignant behaviour, suggesting that PROX1 is a promising target for the development of future therapies for colon cancer.


'/>"/>

Contact: Kari Alitalo
kari.alitalo@helsinki.fi
358-505-003-572
University of Helsinki
Source:Eurekalert

Page: 1

Related medicine news :

1. Investigators unveil new drug discovery tool for Alzheimers disease
2. Discovery to hasten new malaria treatments, vaccines for children
3. Life Sciences Discovery Fund Awards $2.2 Million to Support New Solid-Tumor Research Program
4. World-first discovery could help treat life-threatening tumors
5. St. Jude Discovery Offers New Avenues to Understanding an Aggressive Form of Leukemia
6. St. Jude discovery offers new avenues to understanding an aggressive form of leukemia
7. Jefferson scientists discovery may help explain smoking-pancreatic cancer link
8. Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS
9. Mitosis gets harder thanks to new gene discovery
10. ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
11. GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 04, 2015 Takeda Pharmaceuticals Corp. has ... settle thousands of Actos lawsuits ( http://www.theactoslawsuitcenter.com/ ) ... risk that a patient will develop bladder cancer. According ... 95% of those eligible for the Actos settlement accept ... cancer cases currently pending in courts around the country, ...
(Date:5/4/2015)... 04, 2015 “ LiveSchool ” was ... which takes a look at the latest and coolest ... Joe Toohey, the host of AppWatch and technology expert, ... this application allows teachers to reward students with good ... realize, especially in the classroom. And the good ...
(Date:5/4/2015)... Jacksonville, Fla. (PRWEB) May 04, 2015 ... American Heart Association/American Stroke Association’s Get With The ... the Target: Stroke Honor Roll. The award recognizes ... stroke patients receive the most appropriate treatment according ... latest scientific evidence. , To receive the Gold ...
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... While the World Cup is the most known soccer ... the International Champions Cup is one of the biggest tournaments ... record for soccer in the United States set when Manchester ... University of Michigan. This year, the defending champion Manchester United ...
(Date:5/4/2015)... May 04, 2015 Ticket Down is a ... Colonial Life Arena in Columbia, South Carolina. Fans ... of his “Out There” tour which originally kicked off in ... is North America and the legendary performer recently announced that ... Wells Fargo Arena on June 21st, in Charlottesville, VA at ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2
... for Drug and Social Policy Research (CDSPR) has been awarded ... to study the long-term consequences of adolescent gang membership among ... next four years. , "This is a follow-up to ... members in west San Antonio," said Avelardo Valdez, principal investigator ...
... Feb. 12 Harris Corporation,(NYSE: ... technology,company, has been awarded a ten-year contract ... system, to provide network,management and IT services ... Health First Infrastructure Services (HFIS) contract includes,software ...
... with acute osteomyelitis--a bacterial bone infection--an early changeover from ... as effective as continuing the IV therapy, according to ... are more convenient for children and families, and avoid ... complications from using central catheters, such as infections or ...
... play a key role in the prevention and treatment ... , Endothelial cells line the blood vessels and are ... function. , Researchers at the Centenary Institute have ... endothelial cells. , Professor Jenny Gamble, Head ...
... Inc., the leader in,the development of devices for ... the first series of patients have been successfully,treated ... Hospital, Nieuwegein,Utrecht, Netherlands. The MitraClip(R) system is the ... which provides a non-surgical,mitral valve repair option for ...
... by using the benefits of the world,s largest member discount ... American jobs were lost in 2008, and many of those ... more also start the New Year in dire financial situations; ... in household budgets. Unfortunately, some people may consider cuts in ...
Cached Medicine News:Health News:Gang researchers at UH examine health, consequences of long-term gang 2Health News:Health First Healthcare System Awards Harris Corporation Enterprise-wide Network Management and IT Services Contract 2Health News:Health First Healthcare System Awards Harris Corporation Enterprise-wide Network Management and IT Services Contract 3Health News:Early switch from IV to oral meds is effective for children with acute bone infection 2Health News:Deciphering the body's healing secrets 2Health News:First Dutch Patients Treated With the Percutaneous MitraClip(R) System 2Health News:First Dutch Patients Treated With the Percutaneous MitraClip(R) System 3Health News:During Tough Economic Times Remember Your Health - Save With Your AAA Membership on Necessities From Prescriptions to Eyeglasses 2Health News:During Tough Economic Times Remember Your Health - Save With Your AAA Membership on Necessities From Prescriptions to Eyeglasses 3
(Date:5/4/2015)... WHIPPANY, N.J. , May 4, 2015 ... agreement with Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... clinical development for the prevention of thrombosis. Under the ... in areas of high unmet medical need. As ... evaluate the therapeutic profile of ISIS-FXI Rx in ...
(Date:5/4/2015)... 2015   HeartWare International, Inc . (NASDAQ: HTWR ... technologies that are revolutionizing the treatment of advanced heart failure, ... is scheduled to present at the Bank of America Merrill ... on Thursday, May 14, 2015, at 10:00 a.m. ... the Company,s presentation at the conference will be available via ...
(Date:5/4/2015)... , May 4, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... agreement with Bayer HealthCare (Bayer) to develop and commercialize ... the terms of the agreement, Isis is eligible to ... an immediate $100 million up-front payment and a $55 ... Phase 2 study in patients with compromised kidney function. ...
Breaking Medicine Technology:Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
The Programmable MP-3500P-F Power Supply can be applied for any Microfluidic application....
MP-250N and 300N is a new style power supply. It is a versatile microprocessor power supply for horizontal or vertical gel electrophoresis. The unit is programmable and offers constant voltage and co...
Handy 100V Power Supply is Low-cost, compact and lightweight. Easy to operate - either 50 or 100 VDC is selectable as the output voltage. These voltages are sufficient for ordinary electrophoresis....
... Dual Power is a microprocessor-controlled programmable ... high voltage/low current and high current/low ... current section is ideal for sample ... sequencing applications. The low voltage/high current ...
Medicine Products: